Valuation: Boston Scientific Corporation

Market Cap 71.45B 62B 58.06B 53.11B 100B 6,806B 102B 679B 267B 3,400B 268B 262B 11,318B P/E 2026 *
18.4x
P/E 2027 * 19.2x
Enterprise Value 80.16B 69.57B 65.14B 59.59B 112B 7,636B 114B 762B 299B 3,815B 301B 294B 12,699B EV / Sales 2026 *
3.75x
EV / Sales 2027 * 3.44x
Free-Float
82.5%
Yield 2026 *
-
Yield 2027 * -
1 day+0.86%
1 week+7.17%
Current month+5.50%
1 month+10.54%
3 months-11.96%
6 months-35.36%
Current year-48.30%
1 week 47.1
Extreme 47.1
50.16
1 month 42.2
Extreme 42.2
50.16
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap.
04/08/26 Buy

Director

140 0.0000%
03/08/26 Buy

Chief Executive Officer

208,359 0.0141%
31/07/26 Other

Executive/Senior Manager

64,198 0.0043%
Change 5-day change 1-year change 3-year change Capi.($)
+3.27%+7.17%-52.11%-2.80% 71.45B
+0.38%+0.56%+29.20%+5.72% 214B
+0.16%+1.94%+2.46%-21.50% 141B
-0.40%+5.88%-21.17%+20.82% 132B
+0.39%+2.76%+13.62%+12.28% 51.48B
+0.70%+6.67%-14.84%-19.41% 50.15B
+0.16%+1.90%+24.83%+11.91% 39.92B
-0.08%+5.10%+43.92%+37.88% 39.24B
-0.35%+7.04%-20.40%+24.54% 32.2B
+0.10%+0.53%+0.50%-7.36% 31.76B
Average -0.80%+3.90%+0.60%+6.21% 80.33B
Weighted average by Cap. -0.27%+3.30%+2.64%+3.65%

Financials

2026 *2027 *
Net sales 21.37B 18.54B 17.36B 15.88B 29.98B 2,035B 30.37B 203B 79.71B 1,017B 80.22B 78.48B 3,385B 22.34B 19.38B 18.15B 16.6B 31.34B 2,128B 31.75B 212B 83.33B 1,063B 83.87B 82.04B 3,538B
Net income 3.84B 3.34B 3.12B 2.86B 5.39B 366B 5.46B 36.54B 14.34B 183B 14.43B 14.12B 609B 3.74B 3.24B 3.04B 2.78B 5.25B 356B 5.32B 35.54B 13.95B 178B 14.04B 13.73B 592B
Net Debt 8.72B 7.56B 7.08B 6.48B 12.23B 830B 12.39B 82.87B 32.52B 415B 32.73B 32.02B 1,381B 5.45B 4.73B 4.43B 4.05B 7.65B 519B 7.75B 51.83B 20.34B 259B 20.47B 20.02B 864B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
06/08/26 $49.30 +3.27% 21,398,972
05/08/26 $47.74 -2.75% 16,512,147
04/08/26 $49.09 +1.36% 21,565,121
03/08/26 $48.43 +3.64% 20,379,998
31/07/26 $46.73 +1.59% 18,691,884
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
49.30USD
Average target price
62.69USD
Spread / Average Target
+27.16%

Quarterly revenue - Rate of surprise